Introduction {#s1}
============

All over the world, 48.5 million couples have problems with pregnancy, and many children are born with the help of fertility treatments, which primarily occurs in developing countries ([@B1]). After cancer and cardiovascular disease, infertility is the third most common disease ([@B2]). With increasing numbers of couples delaying parenting attempts, the prevalence of infertility is on the rise. Decreased fatality is one of the most important issues in Western countries, and is an essential part of reproductive health ([@B1]), which affects different aspects of life and imposes huge economic burdens on societies ([@B2]). Infertility is affected by various physiological, genetic, environmental, social, infectious, and nutritional factors ([@B1], [@B3]). Assisted reproductive technology (ART) is one of the most important strategies used today to increase the chance of fertility among infertile people ([@B4]). The ART uses many medications and techniques to increase the chance of fertility ([@B5]). Ovulation-inducing drugs are among the most important drugs used for the treatment of infertility, which affect the ovaries by increasing the levels of estrogen, progesterone, and gonadotropins. Complications of these drugs include ovarian hyper-stimulation syndrome, osteoporosis, and adverse pregnancy outcomes ([@B6], [@B7]).

In recent years, there have been many debates about the relationship between ovulation-inducing drugs, infertility treatment, and cancer ([@B8]--[@B10]). Changes in endogenous hormones that occur following the use of these drugs have raised many concerns about the safety of these treatments. Due to increasing infertility and the subsequent increase in the use of fertility drugs in recent years, investigating the long-term effects of these drugs are considerably important. It also raises the following question: Can the use of fertility drugs in the long-term cause cancer? Since understanding the relationship between the use of fertility drugs and cancer is important and due to the lack of comprehensive study in this regard, the present study was conducted to investigate the relationship between infertility drugs and cancer among women.

Materials and Methods {#s2}
=====================

Search Strategy
---------------

To determine the relationship between infertility treatment and cancer, a comprehensive search for reliable articles was carried out in databases such as; Medline, Web of Science Core Collection (Indexes = SCI-EXPANDED, SSCI, A & HCI Timespan), and Scopus (all years), using keywords, including "infertility," "ovulation induction," "cancer," "infertility treatment," "ART," "tumor," "controlled ovarian stimulation," "fertility agents," and "neoplasms." Combinations of these keywords were also used for the search. All keywords were checked with PubMed Medical Subject Heading (MeSH). Then, a manual search was conducted in valid journals for full-text articles and related systematic reviews. All retrieved articles were entered into the Endnote X7 software in one database. In order to reduce errors during the review phase, the PRISMA statement and Moher et al. ([@B11]) guidance were used.

Inclusion Criteria
------------------

Two researchers carefully reviewed the retrieved articles. The criteria for entering the study included; full-text articles, English language and original articles (case-control, retrospective and prospective cohort), the use of keywords in the title or abstract, articles with an abstract, and articles that have reviewed a type of malignancies associated with the use of fertility drugs. *In vitro* fertilization (IVF) and each of the clomiphene citrate regimens, the gonadotropins, human chorionic gonadotropin (hCG), human menopausal gonadotropin (hMG), gonadotropin-releasing hormone (GnRH) agonist, and antagonists were studied alone or in combination.

Exclusion Criteria
------------------

Case reports, case series, systematic reviews, meta- analysis, and animal studies were excluded.

Extracting and Analyzing the Data
---------------------------------

The articles were categorized according to their specific characteristics including the number of participants, type of study, and type of fertility regimen. The risk scale in this study included; Standardized Incidence Ratio (SIR), Incidence Rate Ratio (IRR), Hazard Ratio (HR), and Odds Ratio (OR).

Results {#s3}
=======

Characteristics of the Selected Studies
---------------------------------------

After a comprehensive search through the databases, 320 articles were entered into the study and the references of 41 articles were manually reviewed. Duplicate articles were removed using Endnote software (*n* = 160). During the initial evaluation, 201 articles were selected for the review. After reviewing the title and abstract, 95 articles that were not consistent with the purpose of this study or did not meet the inclusion criteria were removed. The full texts of other articles were carefully examined by two researchers, and 25 articles were removed for scientific reasons (literature review: 9, commentary: 6, not English language: 2, full text not available: 5, editorial: 3). At the end, 81 articles were selected for the review ([Figure 1](#F1){ref-type="fig"}).

![Flowchart of the included eligible studies in review.](fendo-10-00313-g0001){#F1}

Relationship Between Steroid Hormones and Cancer
------------------------------------------------

In general, cancer occurs as a result of the division of mutated cells. Therefore, the hormone and any factor that stimulates the growth of the cells can affect the occurrence of cancer ([@B12]). The relationship between steroid hormones and some types of cancers, such as breast and endometrium cancers, is well-documented ([@B12]--[@B14]). Estrogen, progesterone, and testosterone are steroid hormones that are produced following a series of biological responses and are derived from cholesterol. Estrogen, which is one of the most important female sex hormones, is produced in the ovaries, the adrenal cortex, and the placenta, and leads to the growth of the reproductive system and the development of sexual traits ([@B15]). Based on the results of studies, free estradiol and albumin-bounded estradiol are associated with an increased risk of breast cancer ([@B16]) and can enhance the progression of metastatic breast cancer ([@B17]). High levels of estradiol and estrogen hormones in women with breast cancer contribute to the progression of metastatic breast cancer ([@B18]). Estrogen can contribute to the onset of cancer by affecting the mitosis duplication of epithelial cells. Increasing mitotic activity can play a role in increased probability of mutation and DNA damage, and reduced apoptosis and growth of early tumors ([@B13], [@B19]).

The role of gonadotropins in the occurrence of cancer has also been discussed by researchers. High levels of LH and FSH cause exposure to uncontested estrogen in the menstrual cycle, which contributes to an increase in cancer. On the other hand, stimulating the synthesis of mitogenic growth factors by gonadotropins can contribute to the growth of breast cancer cells ([@B20], [@B21]). In addition, high levels of gonadotrophin, predict a weaker prognosis in people with breast cancer ([@B21]).

Analysis Based on the Type of Cancer ([Table 1](#T1){ref-type="table"})
-----------------------------------------------------------------------

### Breast Cancer

Breast cancer is a multifactorial disease and several risk factors are involved in its onset. The majority of breast cancers are hormone dependent ([@B22]). Several studies have pointed to the etiologic role of endogenous and exogenous hormones in increasing the risk of breast cancer. Therefore, the possible relationship between ovulation-inducing drugs and increased risk of breast cancer has been the subject of discussions by researchers ([@B23]--[@B25]). Compared with normal ovulation cycle, oestradiol concentration increase up to 10-fold in ovulation stimulation cycle ([@B26]). Treatment with fertility drugs is associated with an increased risk of breast cancer diagnosis in the first year after the treatment ([@B27]). The result of a cohort study of 808,834 women showed that the risk of breast cancer increased in individuals who gave birth following ART \[adjusted hazard risk (HR) 1.20, 95% CI 1.01--1.42\]. However, in this study confounding factors such as age of menarche, family history, history of breastfeeding, and obesity were not controlled ([@B28]). In a cohort study, the risk of breast cancer was increased among individuals who used ovulation-inducting drugs, although this risk was not statistically significant in primiparous women ([@B29]). The result of a case-control study of 35--64 years old women showed that, although the use of fertility drugs was not associated with an increased risk of breast cancer in general, the relative risk of breast cancer in people with a hMG use for more than 6 months or 6 cycles was about 2.7--3.8 ([@B30]). A case-control study found that IVF treatment after the age of 30 years was associated with an increased risk of breast cancer, however, the characteristics of breast tumors in subjects treated with IVF did not differ with the general population ([@B31]). Although the results of the above studies suggest a relationship between infertility treatment and the risk of breast cancer, a large, population based cohort study between 1991 and 2010 stated, regardless of infertility treatment, the risk of breast cancer in people who are incapable of conceiving or maintaining fetuses is increased by 2 times ([@B32]). Meanwhile, many researchers could not show a positive relationship between fertility treatment and breast cancer ([@B32]--[@B38]). The result of a cohort study of 98,997 women aged 40--65 years showed no relationship between the risk of breast cancer and infertility treatment, the type of treatment, the type of drug, the age of the person at the start of treatment, and the duration of treatment. The author of this study suggested that infertility treatments may be associated with an increased risk of breast cancer among women with a family history of breast cancer ([@B39]). In a cohort study of 54,362 women, Jensen showed no relationship between the duration of fertility drugs use, the time since the first use of drugs, and the risk of breast cancer ([@B40]). The results of a cohort study pointed to the potential association between family history and the use of ovulation-inducing drugs in the incidence of breast cancer ([@B39]). In general, according to the results of related studies, the relationship between fertility treatment and breast cancer has not been proven.

###### 

Characteristic study of effects of fertility drugs on cancer.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **References**                 **Country**   **Design**     **Period**   **Study**\           **Mean age at**\       **Mean follow**\             **Adjusting**\                                                                                           **Type of infertility treatment**   **Type of malignancy**   **Number of stimulated cycles**   **Effect estimates**                       **Main finding(s)**
                                                                           **population**       **entry (Year)**       **up (Year)**                **factor(s)**                                                                                                                                                                                                                                      
  ------------------------------ ------------- -------------- ------------ -------------------- ---------------------- ---------------------------- -------------------------------------------------------------------------------------------------------- ----------------------------------- ------------------------ --------------------------------- ------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------
  Reigstad et al. ([@B28])       Norway        Cohort         1984--2010   Total:808,834\       Age range:\            16.0\                        Age\                                                                                                     IVF\                                Breast                                                     HR                                         Increased risk of breast cancer in women with ART.
                                                                           Case: 16,626\        Case: 29.7--35.3\      (12,401,121) person- years   Parity\                                                                                                  ICSI                                                                                                                                      
                                                                           Control: 792,208     Control: 22.9--29.9                                 Age at first birth\                                                                                                                                                                                                                                
                                                                                                                                                    Region of residence                                                                                                                                                                                                                                

  Burkman et al. ([@B30])        US            Case-Control   1994--1998   Case: 4,575\         Age range: 35--64                                   Age\                                                                                                     Clomiphene citrate\                 Breast                   \<6-≥6                            OR                                         Increased risk of ductal breast cancer in women who use hMG.
                                                                           Control: 4,682                                                           Race\                                                                                                    hMG                                                                                                                                       
                                                                                                                                                    Strata of study center                                                                                                                                                                                                                             

  Williams et al. ([@B32])       UK            Cohort         1991--2002   Total:255,786        34.5                   8.8\                                                                                                                                                                      Breast\                  1.8                               SIR                                        No association between ART and corpus uteri and invasive breast cancer risk.\
                                                                                                                       (2,257,789 person- years)                                                                                                                                                 Corpus uteri\                                                                                         Increased risks of *in situ* breast\
                                                                                                                                                                                                                                                                                                 Ovary                                                                                                 cancer and invasive and borderline ovarian tumors in women with ART.

  Dor et al. ([@B23])            Israel        Cohort         1981--1992   Total:5,026          34.0                   3.6\                                                                                                                                  Clomiphene citrate\                 Breast\                  1-≥6                              SIR                                        No association between fertility treatment and cancer risk.
                                                                                                                       (18,291 person- years)                                                                                                                hMG\                                Ovary\                                                                                                
                                                                                                                                                                                                                                                             GnRH analogs                        Cervix\                                                                                               
                                                                                                                                                                                                                                                                                                 Endometrium                                                                                           

  Luke et al. ([@B33])           US            Cohort         2004--2009   Total:113,226\       Case: 37.8\            4.8\                         Age at cycle start\                                                                                      FSH clomiphene citrate              Endocrine\               1, 2, 3, 4, or ≥5                 SIR\                                       No association between fertility treatment and cancer risk.
                                                                           Case:\               Control:35.3           (263,457 person-years)       Parity\                                                                                                                                      Melanoma\                                                  HR                                         
                                                                           Control: 53,872                                                          Infertility diagnosis\                                                                                                                       Breast\                                                                                               
                                                                                                                                                    Number of ART cycles\                                                                                                                        Ovary\                                                                                                
                                                                                                                                                    Cumulative FSH dosage\                                                                                                                       Uterine\                                                                                              
                                                                                                                                                    ART outcome                                                                                                                                  Female genital                                                                                        

  Gauthier et al. ([@B39])       France        Cohort         1990--2000   Total:92,555\        Age range: 40--65      9.7                          Education Smoking\                                                                                       Clomiphene citrate\                 Breast                   Mean: 13 months                   RR                                         No association between fertility treatment and breast cancer risk.
                                                                           Case: 6,602\                                                             BMI\                                                                                                     Gonadotropins                                                                                                                             
                                                                           Control:                                                                 Self and familial history of breast cancer\                                                                                                                                                                                                        
                                                                                                                                                    Age at menarche\                                                                                                                                                                                                                                   
                                                                                                                                                    Menopausal status\                                                                                                                                                                                                                                 
                                                                                                                                                    Parity\                                                                                                                                                                                                                                            
                                                                                                                                                    Age at first full term pregnancy                                                                                                                                                                                                                   

  Jensen et al. ([@B40])         Denmark       Cohort         1965-\       Total:54,379                                8.8                          Number of childbirth                                                                                     FSHhCGhMGGnRH                       Breast                                                     RR                                         No association between fertility treatment and breast cancer risk.
                                                              1998                                                                                                                                                                                                                                                                                                                                     

  Sanner et al. ([@B47])         Swedan        Cohort         1961--2004   Total:2,768\         Age range:\            33.0                         Indication of treatment\                                                                                 Clomiphene citrate\                 Ovary                    1--4 cycles                       SIR\                                       No association between hormonal infertility treatment and invasive ovarian epithelial cancer.
                                                                           Case: 1,153\         16--45                                              Age\                                                                                                     Gonadotropins                                                                                  RR                                         
                                                                           Control:1,615                                                            OCP\                                                                                                                                                                                                                                               
                                                                                                                                                    Parity\                                                                                                                                                                                                                                            
                                                                                                                                                    Pelvic surgery before the infertility treatment Pregnancy with completed birth in the follow-up period                                                                                                                                             

  Silva et al. ([@B48])          London        Cohort         1963--1999   Case:7,425\          28.1                   21.4                         Age\                                                                                                     Clomiphene citrate\                 Breast\                  2--3 cycles                       Period-age-standardized mortality (SMR)\   No association between ovulation stimulation drugs and cancer risk.
                                                                           Control: 1,727                                                           Parity                                                                                                   Gonadotropinss                      Uterine\                                                   SIR                                        
                                                                                                                                                                                                                                                                                                 Ovary                                                                                                 

  Potashnik et al. ([@B49])      Israel        Cohort         1960--1984   Total:1,197\         27.5                   17.9\                                                                                                                                 Clomiphene citrate\                 Breast\                                                    SIR                                        No association between fertility drugs and cancer risk.
                                                                           Case: 780\                                  (21,407 person-years)                                                                                                                 hMG                                 Ovary\                                                                                                
                                                                           Control: 417                                                                                                                                                                                                          Uterine\                                                                                              
                                                                                                                                                                                                                                                                                                 Cervix                                                                                                

  Venn et al. ([@B50])           Australia     Cohort         1978--1992   Total:10,358\        Case: 32\              Case: 5.2\                   Age\                                                                                                     IVF                                 Breast\                  Median: 2 cycles                  SIR                                        No association between IVF and cancer risk.
                                                                           Case: 5,564\         Control: 31            Control: 7.6\                Infertility type                                                                                                                             Ovary                                                                                                 
                                                                           Control: 4,794                              (31,272 person-yers)                                                                                                                                                                                                                                                            

  Franceschi et al. ([@B51])     Italy         Case-Control   1992         Case: 195\           Case: 55 Contol: 56                                                                                                                                                                              Ovary                                                      OR                                         No association between ovulation stimulation drugs and cancer risk.
                                                                           Control: 1,339                                                                                                                                                                                                                                                                                                              

  Modan et al. ([@B85])          Israel        Cohort         1964--1974   Total:2,496          28.7                   21.4\                                                                                                                                 Clomiphene citrate\                 Ovary\                                                     SIR                                        No association between ovulation stimulation drugs and ovarian cancer risk.
                                                                                                                       (54,413 person- years)                                                                                                                hMG                                 Endometrium\                                                                                          
                                                                                                                                                                                                                                                                                                 Breast\                                                                                               
                                                                                                                                                                                                                                                                                                 Melanoma\                                                                                             
                                                                                                                                                                                                                                                                                                 Thyroid                                                                                               

  Trabert et al. ([@B53])        US            Cohort         1965--1988   Total:9,825          30.1                   17.6\                        Study site\                                                                                              Clomiphene citrate\                 Ovary                    ≥6                                RR                                         No association between ovulation stimulation drugs and cancer risk.\
                                                                                                                       (256,448 person- years)      Age\                                                                                                     gonadotropins                                                                                                                             (exception: Use of Clomiphene citrate and failure to pregnancy was related to ovarian cancer risk)
                                                                                                                                                    Gravidity                                                                                                                                                                                                                                          

  Jensen et al. ([@B54])         Denmark       Cohort         1963--\      Total:54,362         30                     16.0\                        Parity                                                                                                   Clomiphene citrate\                 Ovary                    1-≥10                             RR                                         No association between fertility drugs and cancer risk.
                                                              1998                                                     (957,454 person-years)                                                                                                                Gonadotropins\                                                                                                                            
                                                                                                                                                                                                                                                             hCG\                                                                                                                                      
                                                                                                                                                                                                                                                             GnRH                                                                                                                                      

  Doyle ([@B86])                 UK            Cohort         1975--1989   Total:5,556                                 43,811 person-years          Age\                                                                                                                                         Breast\                                                    SIR                                        No association between fertility drugs and cancer risk.
                                                                                                                                                    Calendar year\                                                                                                                               Uterine\                                                                                              
                                                                                                                                                    Parity following the last treatment cycle                                                                                                    Ovary                                                                                                 

  Stewart et al. ([@B87])        Australia     Cohort         1982--2002   Total:21,639\        31.2                   16.5\                        Age\                                                                                                     IVF                                 Ovary                                                      HR                                         Increased risk of borderline ovarian tumors in women with IVF
                                                                           Case: 7,544\                                (365,775 person- years)      Socioeconomic\                                                                                                                                                                                                                                     
                                                                           Control: 14,095                                                          status                                                                                                                                                                                                                                             

  Mosgaard et al. ([@B58])       Denmark       Case-Control   1989--1994   Case: 231\           Case: 43.6\                                         Age\                                                                                                     Clomiphene citrate\                 Ovary                                                      OR                                         No association between fertility drugs and borderline ovarian cancer risk.
                                                                           Control: 1,721       Control: 46.0                                       Region of residence Use of oral contraceptives\                                                          hCG\                                                                                                                                      
                                                                                                                                                    Use of hormone replacement therapy\                                                                      hMG                                                                                                                                       
                                                                                                                                                    Smoking                                                                                                                                                                                                                                            

  Bjørnholt et al. ([@B59])      Denmark       Cohort         1963--2006   Total:96,545         30.3                   11.3\                        Parity\                                                                                                  hCG\                                Ovary                    1-≥4                              RR                                         No association between fertility drugs and borderline ovarian cancer risk.
                                                                                                                       (1,222,252 person- years)    Cause of infertility                                                                                     clomiphene citrate\                                                                                                                       
                                                                                                                                                                                                                                                             Gonadotropins\                                                                                                                            
                                                                                                                                                                                                                                                             GnRH analogs                                                                                                                              

  Liat et al. ([@B24])           Israel        Cohort         1964--1974   Total:2,431          28.6                   33.8\                                                                                                                                 Clomiphene citrate\                 Ovary\                                                     SIR                                        No association between fertility drugs and borderline ovarian cancer risk.\
                                                                                                                       (88,186 person- years)                                                                                                                hMG                                 Breast\                                                                                               Uncertain association between fertility drugs and breast and endometrial cancer risk.
                                                                                                                                                                                                                                                                                                 Endometrium                                                                                           

  Althuis et al. ([@B69])        US            Cohort         1965--1988   Total:8,431          30                     18.8\                        Calendar year\                                                                                           clomiphene citrate\                 Uterine                  \<6-≥6                            RR                                         Increased risk of uterine cancer in women who use clomiphene citrate
                                                                                                                       (155,658 person- years)      Age\                                                                                                     Gonadotropins                                                                                                                             
                                                                                                                                                    Study site                                                                                                                                                                                                                                         

  Jensen et al. ([@B70])         Denmark       Cohort         1965--1998   Total:54362          30                     16.0\                        Parity                                                                                                   Clomiphene citrate\                 Uterine                  1-≥10                             RR                                         Increased risk of uterine cancer in women who use gonadotropins, clomiphene and human chorionic gonadotropin
                                                                                                                       (957,887 person- years)                                                                                                               Gonadotropins\                                                                                                                            
                                                                                                                                                                                                                                                             hCG\                                                                                                                                      
                                                                                                                                                                                                                                                             GnRH                                                                                                                                      

  Hannibal et al. ([@B88])       Denmark       Cohort         1963--\      Total:54,362         30                     8.8                          Age at first live birth\                                                                                 Clomiphene citrate\                 Thyroid                  1-≥6                              RR                                         Increased risk of thyroid cancer in women who use clomiphene
                                                              1998                                                                                  Use of OCP\                                                                                              Gonadotropins\                                                                                                                            
                                                                                                                                                    Parity                                                                                                   hCG\                                                                                                                                      
                                                                                                                                                                                                                                                             GnRH                                                                                                                                      

  Calderon-Margalit. ([@B29])    Israel        Cohort         1974--2004   Total:14,463         Case: 28.1\            29.0\                        Age\                                                                                                     Clomiphene citrate                  Breast\                                                    HR                                         No association between fertility drugs and ovarian cancer risk.\
                                                                                                Control:27.5           (424,193 person- years)      Socioeconomic status\                                                                                                                        Uterus\                                                                                               Increased risk of uterine and borderline breast cancer, malignant melanoma and non-Hodgkin lymphoma in women who use ovulation induction
                                                                                                                                                    Mother\'s geographic origin\                                                                                                                 Ovary\                                                                                                
                                                                                                                                                    Body mass index\                                                                                                                             Cervix\                                                                                               
                                                                                                                                                    Parity                                                                                                                                       Non-Hodgkin lymphoma\                                                                                 
                                                                                                                                                                                                                                                                                                 Malignant melanoma\                                                                                   
                                                                                                                                                                                                                                                                                                 Thyroid\                                                                                              
                                                                                                                                                                                                                                                                                                 Colon                                                                                                 

  Kallen et al. ([@B84])         Swedan        Case-Control   1982--2006   Case:24,058\         32.0                                                Year of delivery\                                                                                        IVF                                 Breast\                                                    OR                                         Decreased risk of breast and cervical cancer in women with IVF
                                                                           Control: 1,394,061                                                       Maternal age\                                                                                                                                Cervix\                                                                                               
                                                                                                                                                    Parity\                                                                                                                                      Ovary\                                                                                                
                                                                                                                                                    Smoking                                                                                                                                      Placenta\                                                                                             
                                                                                                                                                                                                                                                                                                 CNS\                                                                                                  
                                                                                                                                                                                                                                                                                                 Malignant melanoma\                                                                                   
                                                                                                                                                                                                                                                                                                 Thyroid\                                                                                              
                                                                                                                                                                                                                                                                                                 Colon                                                                                                 

  Leeuwen et al. ([@B63])        Netherlands   Cohort         1983--2007   Case: 19,146\        At end of follow up\   14.7                         Age\                                                                                                     IVF                                 Ovary                    1-≥5                              SIR                                        Increased risk of borderline ovarian cancer in women with IVF
                                                                           Control:6,006        Case:47.5\                                          Parity\                                                                                                                                                                                                                                            
                                                                                                Control:49.4                                        Subfertility cause                                                                                                                                                                                                                                 

  Orgéas et al. ([@B89])         Sweden        Cohort         1961--2004   Total:1,135          27                     35,092 person- years         Age\                                                                                                     Clomiphene citrate\                 Breast                   1-≥4                              SIR                                        No association between fertility drugs and breast cancer risk.
                                                                                                                                                    Calendar period of breast cancer diagnosis\                                                              Gonadotropins                                                                                                                             
                                                                                                                                                    Age at first birth\                                                                                                                                                                                                                                
                                                                                                                                                    Parity                                                                                                                                                                                                                                             

  Lundburg et al. ([@B90])       Sweden        Cohort         1982--2012   Total:1,340,211                             Case: 9.6\                   Age\                                                                                                     Clomiphene citrate\                 Breast                                                     HR                                         No association between ovarian stimulation and breast cancer risk.
                                                                                                                       Control: 14.6                Parity\                                                                                                  Gonadotropins                                                                                                                             
                                                                                                                                                    Calendar time\                                                                                                                                                                                                                                     
                                                                                                                                                    Educational level\                                                                                                                                                                                                                                 
                                                                                                                                                    Country of birth\                                                                                                                                                                                                                                  
                                                                                                                                                    Family history of breast cancer\                                                                                                                                                                                                                   
                                                                                                                                                    Age at first birth                                                                                                                                                                                                                                 

  Kessous et al. ([@B46])        Israel        Cohort         1988--2013   Total:10,6031        Case: 30.4\            11.6                         Maternal age\                                                                                                                                Ovary\                                                     HR                                         Increased risk of ovarian and uterine cancer in women who used fertility treatment
                                                                                                Control: 28.3                                       Obesity                                                                                                                                      Uterine\                                                                                              
                                                                                                                                                                                                                                                                                                 Cervix\                                                                                               
                                                                                                                                                                                                                                                                                                 Breast                                                                                                

  Kristiansson et al. ([@B91])   Sweden        Cohort         1981--2001   Case: 8,716\         Age range:21--43       Case: 6.2\                   Age at follow-up\                                                                                        IVF                                 Ovary\                                                     RR                                         decreased incidence of carcinoma *in situ* of the cervix and breast cancer in women who used fertility treatment
                                                                           Control: 64,0059                            Control: 7.8                 Calendar year at follow-up\                                                                                                                  Uterine\                                                                                              
                                                                                                                                                    Number of siblings and multiple births\                                                                                                      Cervix\                                                                                               
                                                                                                                                                    Age at first conception                                                                                                                      Breast                                                                                                

  Pappo et al. ([@B92])          Israel        Cohort         1986--2003   Total:3,375          32.1                   8.1\                         Age\                                                                                                                                         Breast                   1--18                             SIR                                        Increased risk of breast cancer in women who used fertility treatment
                                                                                                                       (27,327 person-years)        Continent of birth\                                                                                                                                                                                                                                

  Spaan et al. ([@B81])          Netherlands   Cohort         1989--2013   Case: 19,157\                               Case: 20.7\                  Age\                                                                                                     IVF                                 Colon                    1-≥7                              SIR                                        No association between IVF and colorectal cancer risk.
                                                                           Control:5,950                               Control: 23.5                Parity\                                                                                                                                                                                                                                            
                                                                                                                                                    IVF cycles                                                                                                                                                                                                                                         
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Ovarian Cancer

Ovarian cancer is a rare and the most fatal gynecological disease worldwide ([@B41]). Regardless of infertility treatments, the risk of ovarian cancer may be altered with nulliparity ([@B24]), and infertility ([@B42], [@B43]). Therefore, the relationship between infertility treatment and ovarian cancer is difficult to prove. The "incessant ovulation theory" states that uninterrupted ovulation can contribute to the development of ovarian cancer by damaging ovary epithelium and, therefore, any factor that contributes to the reduction of ovulation can have a protective effect against ovarian cancer ([@B44]). Many studies have indicated that an increased risk of ovarian cancer is associated with the intake of clomiphene citrate and gonadotropin ([@B25], [@B45]). A cohort study conducted from 1988 to 2013 revealed that, the risk of ovarian cancer is increased in individuals treated with IVF (adjusted HR 3.9; 95% CI 1.2--12.6), ([@B46]). The results of a cohort study showed an increase in the incident of ovarian cancer after exposure to clomiphene citrate. The results also indicated that risk of cancer increases with increasing dosage of the drug among nulliparous women ([@B25]). Use of clomiphene citrate, due to ovulation disorders, increases the risk of ovarian cancer (SIR = 7.47; 95% CI 1.54--21.83), ([@B47]). Although a number of studies have suggested that using ovulation-inducing drugs is associated with ovarian cancer, many of them have not shown any significant increase in the risk of ovarian cancer by taking ovulation-inducing drugs ([@B29], [@B33], [@B48]--[@B52]). The result of a retrospective cohort study showed that women who use clomiphene citrate and remained nulligravid are more likely to develop ovarian cancer than those who use this drug and get pregnant (RR 3.63, 95% CI 1.36--9.72 vs. RR 0.88, 95% CI 0.47--1.63), ([@B53]). In a cohort study of 54,362 women, authors reported that the risk of ovarian cancer does not increase with the use of clomiphene citrate, gonadotropins, human chorionic gonadotropin, and gonadotropin-releasing hormone, and that there is no relationship between the duration of drug use, duration of follow-up, and pregnancy ([@B54]). An increased risk of ovarian cancer among those taking ovulation-inducing drugs should be an issue of interest to therapists and, therefore, more attention should be paid to the people\'s choices ([@B45]).

In several studies, researchers have investigated the relationship between borderline ovarian tumors and fertility treatments. The risk to develop borderline ovarian tumors increased in women undergoing IVF, while childbirth, hysterectomy and sterilization do not have protective effects ([@B55]). In a cohort study, the use of clomiphene citrate and gonadotropins increased the risk of borderline ovarian tumors by up to 3 times (SIR = 3.61; 95% CI 1.45--7.44), ([@B47]). A case-control study showed a relationship between borderline ovarian tumors and the use of ovulation-inducing drugs, especially hMG ([@B56]). The result of a study revealed that, although treatment with clomiphene citrate for \<1 year is not associated with an increase in the risk of borderline tumors, its prolonged use increases this risk ([@B57]). In a case-control study, researchers concluded that, regardless of treatment, the risk of borderline ovarian tumors is two times higher in nulliparous women ([@B58]). Other researchers, however, could not show such a relationship ([@B59], [@B60]). A case-control study examined the correlation between five groups of fertility drugs including clomiphene citrate, human menopausal gonadotropins and follicle stimulating hormone, gonadotropin-releasing hormone analogs, human chorionic gonadotropins, progesterone and borderline ovarian tumors. The study found that use of progesterone was associated with an increased in borderline ovarian tumors, especially serous tumors, but no correlation was found between the borderline ovarian tumors and the use of other drugs ([@B59]). There is an ongoing debate about the relationship between fertility treatments and the risk of ovarian cancer and, so far, there has been no definitive evidence to confirm such relationship ([@B24], [@B61], [@B62]). The relationship between these drugs and the borderline ovarian tumors has only been reported in some studies ([@B56], [@B63], [@B64]).

### Endometrial and Uterine Cancer

Endometrial cancer is one of the hormone-related cancers. Although the relationship between endometrial cancer and ovulation-inducting drugs is not clear, it appears that these drugs increase mitosis activity, DNA replication, mutation and malignancy by increasing serum level of estradiol during the follicular phase ([@B65]). However, by increasing oocyte cycles and pregnancy, the level of progesterone is significantly increased, and this plays a protective role against endometrial cancer. Results of several cohort studies showed an increase in endometrial cancer among women who used clomiphene citrate ([@B24], [@B25]). In a cohort study, researchers reported the highest increase in endometrial cancer among nulliparous women and those who have used more than 6 cycles of clomiphene ([@B25]). A cohort study which lasted for 30-years revealed that infertility is associated with an increased risk of endometrial cancer, and this risk does increase by ovulation induction ([@B24]). This is consistent with the finding of Brinton\'s study ([@B66]). The results of a case- control study supported previous research and stated duration of use of fertility drugs was positively associated with endometrial cancer risk (OR = 6.10; 95% CI, 0.96--38.6) ([@B67]). There have been a few studies that did not show any relationship between fertility treatment and endometrial cancer ([@B68]).

According to a cohort of 29,700 IVF women, the incidence of uterine sarcoma increases in women who have history of infertility ([@B8]). In a large cohort study, authors reported that the risk of uterine cancer in people taking ovulation-stimulating drugs is increased by 3 times, and this risk will increase by 8 times after taking clomiphene citrate for 12 months ([@B29]). Based on the results of a retrospective cohort study, the risk of uterine cancer increases with the increase in the dose of clomiphene citrate, its cycle of use, and the time since its first use, The risk is also increased in nulligravid and obese individuals ([@B69]). A cohort study concluded that consumption of more than 2,250 mg of clomiphene is associated with a 2.6-fold increase in the risk of uterus cancers ([@B48]). In 2009, researchers in a population based cohort study pointed to the relationship between the high dosages of gonadotropins and hCG and uterine cancer among the gonadotropins and hCG users ([@B70]). Infertility drugs may increase estrogen level during the follicular phase of ovulation stimulation cycles, and use of hCG and clomiphene for more than 6 months may increase the risk of uterine cancer ([@B54]). In general, uterine and endometrial cancers do not have high prevalence among different age groups, especially young people who are the target group in most studies, and therefore it is challenging to determine the relationship between endometrial cancer and the use of ovulation-inducing drugs.

### Thyroid Cancer

The effect of exogenous hormonal agents on estrogen dependent malignancies has been discussed by many researchers. Stimulation of ovulation is associated with increased level of TSH hormone in the circulation, which causes cell proliferation in the gland ([@B25]). Some medications, such as clomiphene citrate, may have a greater effect on the thyroid gland due to longer half-life ([@B71]). The results of various studies suggest a link between thyroid cancer and ART ([@B25], [@B71]). A cohort study concluded that, the use of clomiphene citrate is associated with a 2-fold increase in the risk of thyroid cancer, and this risk is not statistically significant among the users of gonadotropins, hCG, and GnRH ([@B71]). The risk of thyroid cancer is higher among nulligravid women who take clomiphene citrate ([@B72], [@B73]). However, in a cohort study, the risk of thyroid cancer was higher among parous individuals who were taking clomiphene citrate ([@B71]). The use of clomiphene (RR = 2.28; 95% CI: 1.08--4.82) and progesterone (RR = 10.14; 95% CI: 1.93--53.33) is associated with an increased risk of thyroid cancer ([@B71]). Other studies have not shown any relationship between fertility drugs and thyroid cancer. Authors in a cohort study stated that there is no evidence of any relationship between gonadotropins and thyroid cancer ([@B73]). In a study, aggressive pattern of papillary thyroid carcinoma was seen among thyroid cancer patients who had received IVF treatment in the past and this may cause a delay in the thyroid cancer diagnosis. In this study, thyroid cancer was diagnosed after 4 years from the last IVF treatment ([@B74]). The present study did not find any relationship between fertility treatment and thyroid cancer.

### Skin Cancer

Skin cancer endangers many people\'s lives due to death or disability. Age, gender, diet, and genetics affect incidence of this cancer ([@B75]). Potential effect of oral contraceptive pills on melanoma ([@B76], [@B77]), has been a source of concern for researchers about the role of fertility drugs on this cancer. In a cohort study, the incident of skin cancer (except melanoma) was higher in those who were using IVF treatment ([@B78]). Researchers stated that, although in general infertility treatment is not associated with the risk of malignant melanoma, the use of clomiphene citrate is associated with an increased risk of malignant melanoma, and this risk is more pronounced among those who have been waiting for pregnancy for more than a year ([@B29]). In a cohort study, authors concluded that although infertility is not associated with an increased risk of malignant melanoma, exposure to fertility drugs in women with infertile partners increases the risk of melanoma, and this risk is also reduced in women who receive a low dose of fertility drugs ([@B79]). According to a retrospective cohort study, infertile women with progesterone deficiencies had higher melanoma risk ([@B80]). In a retrospective cohort study among 8,422 women in 1965--1988, the researchers confirmed this result and concluded that, the use of fertility treatment does not significantly alter the risk of melanoma. In this study, clomiphene citrate had a stronger effect on the risk of melanoma (RR = 2; 95% CI:0.9--4.6) ([@B73]). Overall, the results of studies have shown no relationship between the risk of melanoma and fertility drugs.

### Colon Cancer

Although lifestyle is one of the most important risk factors for colon cancer, sex hormones may also affect the etiology of colon cancer. The results of a cohort study showed that infertility treatment does not increase the risk of colon cancer ([@B73]). The result of a 21-year follow-up in a cohort study showed that ovarian stimulation for IVF does not increase the risk of breast cancer in comparison with the general population ([@B81]). Furthermore, after a 30 year follow-up of 9,892 women treated with pre- IVF fertility drugs, researchers found that these drugs have no effect on colorectal cancer. The increase in IVF cycles and a greater amount of gonadotropin ampoules did not alter this risk ([@B72]). Other studies showed that ovulation stimulation for IVF does not increase the risk of colon cancer in comparison with the general population ([@B48], [@B81]). Estrogen is considered to be protective against colorectal cancer ([@B82]), and so this cancer is expected to decrease in women who use fertility drugs. In addition, lower level of insulin- like growth factor I in women who use exogenous hormones, may play a role in reducing colorectal cancer in these group ([@B81]). Generally, the results of present study suggest that fertility treatment is not a risk factor for colon cancer.

### Cervical Cancer

Cervical cancer is the fourth most common cancer among women ([@B83]). Twenty years follow up of 8,422 women during 1965--1988 showed that infertility treatment does not change the risk of cervical cancer ([@B73]). According to a cohort study, ovulation induction reduces the risk of cervical cancer ([@B48]). Other cohort studies reported a lower risk of cervical cancer in people undergoing IVF treatment ([@B23], [@B78], [@B84]). Ultimately, researchers have reported that, due to regular screening and periodic examinations of infertile people, the risk of cervical cancer is lower among these people ([@B25]). In addition, parity and full- term pregnancy increase the risk of cervical cancer, therefore, it seems that this cancer is less prevalent among infertile women ([@B83]).

Non-Hodgkin\'s Lymphoma
-----------------------

Ovulation induction is associated with an increased risk of non-Hodgkin\'s lymphoma, and this risk is more pronounced in primiparous women as well as the first 5 years after childbirth (HR 2.63, 95% CI: 1.02, 6.82) ([@B29]).

Conclusion {#s4}
==========

The purpose of this study was to determine the relationship between the use of fertility drugs and cancer. Due to the correlation between hormonal and reproductive factors and women\'s cancers, much more attention has been paid to the relationship between the use of fertility drugs and cancer in recent years. Although this relationship is theoretically justifiable, the complex and multiple factors that are involved in the onset of cancer make it difficult to determine the definite relationship between the use of these drugs and cancer. In spite of the relationship that exists between the ovulation-inducing drugs and cancer in some cohort studies, the results of our study showed no significant increase in the incidence of cancer by infertility treatment. According to the results of this study, there is no definitive relationship between the use of fertility drugs and cancer, and only some observational studies have pointed to this relationship. So, the following question still cannot be answered: Are fertility drugs safe?

Although, the small sample size, short-term follow-up, and lack of control over confounding variables are some of the most important limitations of such studies, more studies are needed to achieve a better result. Since, the large proportion of people who use ovulation-inducing drugs are young, long-term follow-up can better detect the onset of cancer among them. At the end, the relationship between infertility treatment and cancer incidence remains an open question.
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